Omeros sells eye surgery product to Rayner for $126M in cash by Charlotte Schubert on December 23, 2021December 23, 2021 at 10:59 am Seattle biotech Omeros completed a deal Thursday to sell Omidria, a product used in eye surgery, to Rayner Surgical Group. United Kingdom-based Rayner acquired the Omidria franchise for $126 million.… Read More